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The European Journal of Clinical Microbiology and
Infectious Diseases is a healthy journal, with over 600
submitted manuscripts annually. Most of these papers are in
the clinical microbiology sector (59%), with manuscripts on
virology (15%) and fungal infections (10%) ranking second
and third. However, over 50% of this impressive input has
to be rejected immediately and, among the manuscripts that
are sent out for peer review, another 30–40% will, in the
end, not be acceptable for publication. Primarily, this is
related to the relative quality of the various submissions:
some are simply better than others and our review process
is aimed at selecting these top papers. On the other hand,
we are faced with a continuously increasing number of
submissions, an increase that is significantly larger than
what we will ever be able to publish in the end. As a result,
we are now facing a backlog with respect to ‘paper
publication,’ although our electronic publishing system is
as timely as it could ever be: within three weeks of
acceptance of your manuscripts, these will be listed in
PubMed and will also be directly downloadable from that
resource. We explain the backlog as being the visible result
of the increasing quality of the submitted manuscripts. In
order to accommodate for this higher level of page
consumption, Springer, our publisher, will allow a 5%
increase of our page budget for 2009.
Still, and because of the backlog that we are now facing,
we will have to change our submission policy. In the
coming year, the authors’ instructions will be changed to
explain these changes in more detail. Most visibly, we will
change the manuscript categories. The Letters to the Editor
section will disappear, as will the Concise Article category,
leaving us with Reviews, Regular Articles and Brief
Reports. For the latter categories, we will introduce word
count caps of around 2,500 and 750, respectively. However,
Springer will facilitate the publication of Supplementary
Material through their Web-based system. Simultaneously,
we will try to acquire more reviews, which will be
facilitated by the appointment of a review editor early this
year. Finally, we will establish an advisory board, the
members of which will be asked to continuously review the
quality of the journal, with a clear focus on improving
the journal further. We hope that this set of measures will
guarantee further improvement of the journal and that you,
as readers and authors, will remain as dedicated to the
journal as you have been over the past years.
I wish to thank all of the authors for their willingness to
share their data with us, my gratitude goes to the hundreds
of reviewers that help us assess the quality of the manu-
scripts that are submitted, and you as readers for your
continued support of the journal. Last but not least, Nele
Jung, who runs the Editorial Office, needs to be acknowl-
edged for performed a smooth job in channelling all of the
manuscripts that are submitted.
This leaves me with nothing else than to wish you a
prosperous and scientifically successful 2009. I do hope
that you will be considering the European Journal of
Clinical Microbiology and Infectious Diseases as a worthy
forum for the publication of your best work.
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